In this report, the United States Endocrinology Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Endocrinology Drugs in these regions, from 2013 to 2025 (forecast).
United States Endocrinology Drugs market competition by top manufacturers/players, with Endocrinology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
AbbVie
GSK
Bayer
Astellas Pharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Thyroid hormone disorder drugs
Diabetes drugs
Human growth hormone
Testosterone replacement therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Drugstore
Hospital
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Endocrinology Drugs Market Report 2018
1 Endocrinology Drugs Overview
1.1 Product Overview and Scope of Endocrinology Drugs
1.2 Classification of Endocrinology Drugs by Product Category
1.2.1 United States Endocrinology Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Endocrinology Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Thyroid hormone disorder drugs
1.2.4 Diabetes drugs
1.2.5 Human growth hormone
1.2.6 Testosterone replacement therapy
1.3 United States Endocrinology Drugs Market by Application/End Users
1.3.1 United States Endocrinology Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 United States Endocrinology Drugs Market by Region
1.4.1 United States Endocrinology Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Endocrinology Drugs Status and Prospect (2013-2025)
1.4.3 Southwest Endocrinology Drugs Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Endocrinology Drugs Status and Prospect (2013-2025)
1.4.5 New England Endocrinology Drugs Status and Prospect (2013-2025)
1.4.6 The South Endocrinology Drugs Status and Prospect (2013-2025)
1.4.7 The Midwest Endocrinology Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Endocrinology Drugs (2013-2025)
1.5.1 United States Endocrinology Drugs Sales and Growth Rate (2013-2025)
1.5.2 United States Endocrinology Drugs Revenue and Growth Rate (2013-2025)
2 United States Endocrinology Drugs Market Competition by Players/Suppliers
2.1 United States Endocrinology Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Endocrinology Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Endocrinology Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Endocrinology Drugs Market Competitive Situation and Trends
2.4.1 United States Endocrinology Drugs Market Concentration Rate
2.4.2 United States Endocrinology Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Endocrinology Drugs Manufacturing Base Distribution, Sales Area, Product Type
3 United States Endocrinology Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Endocrinology Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Endocrinology Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Endocrinology Drugs Price by Region (2013-2018)
4 United States Endocrinology Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Endocrinology Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Endocrinology Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Endocrinology Drugs Price by Type (2013-2018)
4.4 United States Endocrinology Drugs Sales Growth Rate by Type (2013-2018)
5 United States Endocrinology Drugs Sales (Volume) by Application (2013-2018)
5.1 United States Endocrinology Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Endocrinology Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Endocrinology Drugs Players/Suppliers Profiles and Sales Data
6.1 Novo Nordisk
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Endocrinology Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.2 Endocrinology Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.2 Endocrinology Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Eli Lily
6.4.2 Endocrinology Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eli Lily Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Endocrinology Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 AbbVie
6.6.2 Endocrinology Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AbbVie Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 GSK
6.7.2 Endocrinology Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 GSK Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Bayer
6.8.2 Endocrinology Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Astellas Pharma
6.9.2 Endocrinology Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Astellas Pharma Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
7 Endocrinology Drugs Manufacturing Cost Analysis
7.1 Endocrinology Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endocrinology Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Endocrinology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endocrinology Drugs Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Endocrinology Drugs Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Endocrinology Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Endocrinology Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Endocrinology Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Endocrinology Drugs Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Endocrinology Drugs
Figure United States Endocrinology Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Endocrinology Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Thyroid hormone disorder drugs Product Picture
Figure Diabetes drugs Product Picture
Figure Human growth hormone Product Picture
Figure Testosterone replacement therapy Product Picture
Figure United States Endocrinology Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Endocrinology Drugs by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Endocrinology Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Endocrinology Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Endocrinology Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Endocrinology Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Endocrinology Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Endocrinology Drugs Sales Share by Players/Suppliers
Figure 2017 United States Endocrinology Drugs Sales Share by Players/Suppliers
Figure United States Endocrinology Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Endocrinology Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Endocrinology Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Endocrinology Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Endocrinology Drugs Revenue Share by Players/Suppliers
Table United States Market Endocrinology Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Endocrinology Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Endocrinology Drugs Market Share of Top 3 Players/Suppliers
Figure United States Endocrinology Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Endocrinology Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Endocrinology Drugs Product Category
Table United States Endocrinology Drugs Sales (K Units) by Region (2013-2018)
Table United States Endocrinology Drugs Sales Share by Region (2013-2018)
Figure United States Endocrinology Drugs Sales Share by Region (2013-2018)
Figure United States Endocrinology Drugs Sales Market Share by Region in 2017
Table United States Endocrinology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Endocrinology Drugs Revenue Share by Region (2013-2018)
Figure United States Endocrinology Drugs Revenue Market Share by Region (2013-2018)
Figure United States Endocrinology Drugs Revenue Market Share by Region in 2017
Table United States Endocrinology Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Endocrinology Drugs Sales (K Units) by Type (2013-2018)
Table United States Endocrinology Drugs Sales Share by Type (2013-2018)
Figure United States Endocrinology Drugs Sales Share by Type (2013-2018)
Figure United States Endocrinology Drugs Sales Market Share by Type in 2017
Table United States Endocrinology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Endocrinology Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Endocrinology Drugs by Type (2013-2018)
Figure Revenue Market Share of Endocrinology Drugs by Type in 2017
Table United States Endocrinology Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Endocrinology Drugs Sales Growth Rate by Type (2013-2018)
Table United States Endocrinology Drugs Sales (K Units) by Application (2013-2018)
Table United States Endocrinology Drugs Sales Market Share by Application (2013-2018)
Figure United States Endocrinology Drugs Sales Market Share by Application (2013-2018)
Figure United States Endocrinology Drugs Sales Market Share by Application in 2017
Table United States Endocrinology Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Endocrinology Drugs Sales Growth Rate by Application (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure Merck Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure Merck Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table Eli Lily Basic Information List
Table Eli Lily Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lily Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure Eli Lily Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure Eli Lily Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure AstraZeneca Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure AbbVie Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure AbbVie Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure GSK Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure GSK Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure Bayer Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure Bayer Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astellas Pharma Endocrinology Drugs Sales Growth Rate (2013-2018)
Figure Astellas Pharma Endocrinology Drugs Sales Market Share in United States (2013-2018)
Figure Astellas Pharma Endocrinology Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endocrinology Drugs
Figure Manufacturing Process Analysis of Endocrinology Drugs
Figure Endocrinology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Endocrinology Drugs Major Players/Suppliers in 2017
Table Major Buyers of Endocrinology Drugs
Table Distributors/Traders List
Figure United States Endocrinology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Endocrinology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Endocrinology Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Endocrinology Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Endocrinology Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Endocrinology Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Endocrinology Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Endocrinology Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Endocrinology Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
